Skip to main content
SpringerLink
Log in

Mailed Fecal-Immunochemical Test for Colon Cancer Screening

  • Original paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Various interventions have been implemented to increase the rate of colon cancer screening. The purpose of this study was to determine if persons who are regular patients of a clinic, ages 50–64 years, and not up-to-date with colon cancer screening will complete the at-home fecal-immunochemical test (FIT) if it is mailed to them. This intervention was designed to have the subject avoid the signing of an informed consent and having to ask for the screening test; and, only one stool specimen was needed. Three hundred and fifty potential subjects were randomly selected from an electronic medical record database after meeting inclusion criteria. Eighty-seven fecal immunochemical tests were returned. Seven of the FIT kit results were positive for occult blood. Each respondent was sent a letter giving them their results. A minimal cue CRC screening intervention, a FIT kit sent in the mail without prerequisite of a signed informed consent, was offered to the study subjects. Twenty-six percent of the eligible persons were screened for colon cancer by this method. A mailed FIT kit or one handed to the patient at an office visit has minimal cost which can be recovered through insurance coverage. Commitment by health care providers is necessary for prevention. This method is one of several that could reach the hard to screen population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. McFarland, E. G., Levin, B., Lieberman, D. A., Pickhardt, P. J., Johnson, C. D., Glick, S. N., Brooks, D., Smith, R. A., American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, & American College of Radiology. (2008). Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology, 248(3), 717–720.

  2. Surveillance, Epidemiology, and End Results (SEER) Program. (2000–2004). SEER Stat Database: Incidence—SEER 17 Regs Limited-Use, Nov 2006. www.seer.cancer.gov. Updated Released April 2007 based on the November 2006 submission.

  3. Shapiro, J. A., Seeff, L. C., Thompson, T. D., Nadel, M. R., Klabunde, C. N., & Vernon, S. W. (2008). Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiology, Biomarkers and Prevention, 17(7), 1623–1630.

    Article  PubMed  Google Scholar 

  4. Vogelaar, I., van Ballegooijen, M., Schrag, D., Boer, R., Winawer, S. J., Habbema, J. D., et al. (2006). How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer, 107(7), 1624–1633.

    Article  PubMed  Google Scholar 

  5. Liang, S. Y., Phillips, K. A., Nagamine, M., Ladabaum, U., & Haas, J. S. (2006). Rates and predictors of colorectal cancer screening. Preventing Chronic Disease, 3(4), A117.

    PubMed  Google Scholar 

  6. Hawley, S. T., Volk, R. J., Krishnamurthy, P., Jibaja-Weiss, M., Vernon, S. W., & Kneuper, S. (2008). Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Medical Care, 46(9 Suppl 1), S10–S16.

    Article  PubMed  Google Scholar 

  7. Klabunde, C. N., Lanier, D., Nadel, M. R., McLeod, C., Yuan, G., & Vernon, S. W. (2009). Colorectal cancer screening by primary care physicians: Recommendations and practices, 2006–2007. American Journal of Preventive Medicine, 37(1), 1–7.

    Article  PubMed  Google Scholar 

  8. Pignone, M., Harris, R., & Kinsinger, L. (2000). Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Annals of Internal Medicine, 133(10), 761–769.

    CAS  PubMed  Google Scholar 

  9. Sequist, T. D., Zaslavsky, A. M., Marshall, R., Fletcher, R. H., & Ayanian, J. Z. (2009). Patient and physician reminders to promote colorectal cancer screening: A randomized controlled trial. Archives of Internal Medicine, 169(4), 364–371.

    Article  PubMed  Google Scholar 

  10. Chan, E. C., & Vernon, S. W. (2008). Implementing an intervention to promote colon cancer screening through e-mail over the Internet: Lessons learned from a pilot study. Medical Care, 46(9 Suppl 1), S117–S122.

    Article  PubMed  Google Scholar 

  11. Khankari, K., Eder, M., Osborn, C. Y., Makoul, G., Clayman, M., Skripkauskas, S., et al. (2007). Improving colorectal cancer screening among the medically underserved: A pilot study within a federally qualified health center. Journal of General Internal Medicine, 22(10), 1410–1414.

    Article  PubMed  Google Scholar 

  12. Vernon, S. W. (1997). Participation in colorectal cancer screening: A review. Journal of the National Cancer Institute, 89(19), 1406–1422.

    Article  CAS  PubMed  Google Scholar 

  13. Yarnall, K. S., Pollak, K. I., Ostbye, T., Krause, K. M., & Michener, J. L. (2003). Primary care: Is there enough time for prevention? American Journal of Public Health, 93(4), 635–641.

    Article  PubMed  Google Scholar 

  14. Levy, B. T., Joshi, M., Xu, Y., Daly, J., & James, P. A. (2008). Perceptions of Iowa family physicians regarding colorectal cancer screening. Medical Care, 46(9 Suppl 1), S103–S108.

    Article  PubMed  Google Scholar 

  15. Schroy, P. C., I. I. I., Lal, S., Glick, J. T., Robinson, P. A., Zamor, P., & Heeren, T. C. (2007). Patient preferences for colorectal cancer screening: How does stool DNA testing fare? American Journal of Managed Care, 13(7), 393–400.

    PubMed  Google Scholar 

  16. Pignone, M. (2007). Patient preferences for colon cancer screening: The role of out-of-pocket costs. American Journal of Managed Care, 13(7), 390–391.

    PubMed  Google Scholar 

  17. Ling, B. S., Moskowitz, M. A., Wachs, D., Pearson, B., & Schroy, P. C. (2001). Attitudes toward colorectal cancer screening tests. Journal of General Internal Medicine, 16(12), 822–830.

    Article  CAS  PubMed  Google Scholar 

  18. Parekh, M., Fendrick, A. M., & Ladabaum, U. (2008). As tests evolve and costs of cancer care rise: Reappraising stool-based screening for colorectal neoplasia. Alimentary Pharmacology & Therapeutics, 27(8), 697–712.

    Article  CAS  Google Scholar 

  19. Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., Johnson, C. D., Levin, T. R., Pickhardt, P. J., Rex, D. K., Smith, R. A., Thorson, A., Winawer, S. J., American Cancer Society Colorectal Cancer Advisory Group, US Multi-Society Task Force, & American College of Radiology Colon Cancer Committee. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology, 134(5), 1570–1595.

  20. Allison, J. E., Sakoda, L. C., Levin, T. R., Tucker, J. P., Tekawa, I. S., Cuff, T., et al. (2007). Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. Journal of the National Cancer Institute, 99(19), 1462–1470.

    Article  PubMed  Google Scholar 

  21. Lee, F. I. (1983). Screening for colorectal cancer in a factory-based population with Fecatest. British Journal of Cancer, 48(6), 843–847.

    CAS  PubMed  Google Scholar 

  22. Sontag, S. J., Durczak, C., Aranha, G. V., Chejfec, G., Frederick, W., & Greenlee, H. B. (1983). Fecal occult blood screening for colorectal cancer in a Veterans Administration Hospital. American Journal of Surgery, 145(1), 89–94.

    Article  CAS  PubMed  Google Scholar 

  23. Slater, P. E., Fich, A., Zimmerman, J., Ever-Hadani, P., & Rachmilewitz, D. (1985). Recruitment of subjects for fecal occult blood screening: A comparison of two methods in Jerusalem. Journal of Clinical Gastroenterology, 7(1), 51–54.

    Article  CAS  PubMed  Google Scholar 

  24. St John, D. J., Young, G. P., Alexeyeff, M. A., Deacon, M. C., Cuthbertson, A. M., Macrae, F. A., et al. (1993). Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology, 104(6), 1661–1668.

    CAS  PubMed  Google Scholar 

  25. Castiglione, G., Zappa, M., Grazzini, G., Mazzotta, A., Biagini, M., Salvadori, P., et al. (1996). Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. British Journal of Cancer, 74(1), 141–144.

    CAS  PubMed  Google Scholar 

  26. Lohsiriwat, V., Thavichaigarn, P., & Awapittaya, B. (2007). A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Journal of the Medical Association of Thailand, 90(11), 2291–2295.

    PubMed  Google Scholar 

  27. Inverness Medical. (2009). Fecal occult blood tests: Clearview ULTRA FOB test. Clearview ULTRA FOB Test Web site. http://www.clearview-fobt.com. Updated 2009. Accessed May 11, 2009.

  28. Church, T. R., Yeazel, M. W., Jones, R. M., Kochevar, L. K., Watt, G. D., Mongin, S. J., et al. (2004). A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. Journal of the National Cancer Institute, 96(10), 770–780.

    PubMed  Google Scholar 

  29. Hardcastle, J. D., Armitage, N. C., Chamberlain, J., Amar, S. S., James, P. D., & Balfour, T. W. (1986). Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer, 58(2), 397–403.

    Article  CAS  PubMed  Google Scholar 

  30. Pye, G., Christie, M., Chamberlain, J. O., Moss, S. M., & Hardcastle, J. D. (1988). A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. Journal of Epidemiology and Community Health, 42(1), 66–71.

    Article  CAS  PubMed  Google Scholar 

  31. Mant, D., Fuller, A., Northover, J., Astrop, P., Chivers, A., Crockett, A., et al. (1992). Patient compliance with colorectal cancer screening in general practice. British Journal of General Practice, 42(354), 18–20.

    CAS  PubMed  Google Scholar 

  32. Greegor, D. H. (1971). Occult blood testing for detection of asymptomatic colon cancer. Cancer, 28(1), 131–134.

    Article  CAS  PubMed  Google Scholar 

  33. Anderson, L. M., & May, D. S. (1995). Has the use of cervical, breast, and colorectal cancer screening increased in the United States? American Journal of Public Health, 85(6), 840–842.

    Article  CAS  PubMed  Google Scholar 

  34. Brown, M. L., Potosky, A. L., Thompson, G. B., & Kessler, L. G. (1990). The knowledge and use of screening tests for colorectal and prostate cancer: Data from the 1987 National Health Interview Survey. Preventive Medicine, 19(5), 562–574.

    Article  CAS  PubMed  Google Scholar 

  35. Schenck, A. P., Peacock, S. C., Klabunde, C. N., Lapin, P., Coan, J. F., & Brown, M. L. (2009). Trends in colorectal cancer test use in the medicare population, 1998–2005. American Journal of Preventive Medicine, 37(1), 1–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA, 52242, USA

    Jeanette M. Daly, Barcey T. Levy, Mary L. Merchant & Jason Wilbur

Authors
  1. Jeanette M. Daly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barcey T. Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary L. Merchant
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jason Wilbur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeanette M. Daly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daly, J.M., Levy, B.T., Merchant, M.L. et al. Mailed Fecal-Immunochemical Test for Colon Cancer Screening. J Community Health 35, 235–239 (2010). https://doi.org/10.1007/s10900-010-9227-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-010-9227-8

Keywords

Search

Navigation